Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

LNTH

Lantheus (LNTH)

Lantheus Holdings Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LNTH
日付受信時刻ニュースソース見出しコード企業名
2025/01/2820 : 30PR Newswire (US)Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical LeaderNASDAQ:LNTHLantheus Holdings Inc
2025/01/2820 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2025/01/2820 : 00GlobeNewswire Inc.Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical LeaderNASDAQ:LNTHLantheus Holdings Inc
2025/01/1314 : 05GlobeNewswire Inc.Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic MarketNASDAQ:LNTHLantheus Holdings Inc
2024/12/2406 : 32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/12/2006 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/11/2020 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/11/2015 : 00GlobeNewswire Inc.Lantheus Announces Share Repurchase ProgramNASDAQ:LNTHLantheus Holdings Inc
2024/11/2006 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/1907 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/1601 : 59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/1500 : 07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/1322 : 30GlobeNewswire Inc.Lantheus to Present at the Jefferies London Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
2024/11/1307 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/1121 : 39GlobeNewswire Inc.Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025NASDAQ:LNTHLantheus Holdings Inc
2024/11/0906 : 38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/11/0621 : 42Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LNTHLantheus Holdings Inc
2024/11/0621 : 37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/11/0621 : 00GlobeNewswire Inc.Lantheus Reports Third Quarter 2024 Financial ResultsNASDAQ:LNTHLantheus Holdings Inc
2024/11/0421 : 30GlobeNewswire Inc.Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and CareNASDAQ:LNTHLantheus Holdings Inc
2024/10/2321 : 30GlobeNewswire Inc.Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern TimeNASDAQ:LNTHLantheus Holdings Inc
2024/10/1521 : 28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/09/2605 : 44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/09/1521 : 45GlobeNewswire Inc.Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024NASDAQ:LNTHLantheus Holdings Inc
2024/09/1402 : 29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/09/0521 : 38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LNTHLantheus Holdings Inc
2024/09/0521 : 30GlobeNewswire Inc.Lantheus Appoints Julie Eastland as New Board MemberNASDAQ:LNTHLantheus Holdings Inc
2024/09/0405 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LNTHLantheus Holdings Inc
2024/08/2821 : 30GlobeNewswire Inc.Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:LNTHLantheus Holdings Inc
2024/08/2205 : 35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LNTHLantheus Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:LNTH

最近閲覧した銘柄

Delayed Upgrade Clock